"With the Duplomb law, we are forced to accept the growing risk of cancer."

Interview: Fleur Breteau began chemotherapy just as Parliament began examining this bill, which plans to reauthorize a neonicotinoid pesticide and whose final vote in the National Assembly is scheduled for Tuesday. By creating the Cancer Anger collective, she aims to "politicize" this disease.

Interview by Emilie Brouze

Published on July 8, 2025 at 12:30 p.m.

During a demonstration against the Duplomb bill, June 30, 2025, in Paris. DIMITAR DILKOFF/AFP

Google News Subscribe to read

Banned in France since 2018, acetamiprid, a neonicotinoid pesticide, could be reauthorized, for several crops and under certain conditions, by the Duplomb bill, named after the Republican senator who initiated it. This is one of the most sensitive measures of this controversial text , aimed at "lifting constraints" on farmers, which is about to be adopted this Tuesday, July 8 afternoon, in the National Assembly during a final vote . "A law for cancer," denounces Fleur Breteau, 50, who is fighting breast cancer, the second in four years. She has just launched the Cancer Anger collective, whose goal is to "politicize" this disease.

Why are you angry about the Duplomb bill?

Fleur Breteau I began my first cycle of chemotherapy last January, just as the Duplomb law was being introduced in the Senate. I was very worried when I read the reactions of Jean-Marc Bonmatin, a toxicologist at the CNRS and a specialist in neonicotinoids, and then when I read the open letter from 1,200 doctors and scientists opposing it. It's an anachronistic law,…

Article reserved for subscribers.

Want to read more?

All our articles in full from €1